13 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... Task Force on Clinical ... #HeartFailure #Management ... #CHF #guideline ... #treatment #algorithm
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... disease or CHF) ... disease or CHF) ... #management #cardiology ... #algorithm
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... : 33% • Treatment ... : Age>60, CKD, CHF ... , and CXR with pulmonary ... : No • Treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Pathophysiology ... Imaging: CXR- pulmonary ... sepsis), PE, DAH, CHF ... APML #diagnosis #management
Alcoholic Hepatitis - Summary Overview
- Epidemiology
- Pathophysiology
- Clinical Features
- Labs
- Diagnosis
- Differential Diagnosis
- Treatment

Sarah Onorato @sonorato11

#Alcoholic
Epidemiology - Pathophysiology ... - Clinical Features ... Alcoholic #Hepatitis #hepatology ... #diagnosis #algorithm ... #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
Signs of congestion ... with presence of pulmonary ... #differential #algorithm ... #management #cardiology ... #heartfailure #chf
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy • Pulmonary ... Clinical • Under-recognized ... May have typical HF ... support for patients clinically ... #cardiology #treatment
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
monophasic Pathophysiology ... Transverse Myelitis - Clinical ... • Bilateral signs ... Transverse Myelitis Treatment ... Myelitis #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... disease b) CHF ... event, follow ACC algorithm ... Change in clinical ... medical and surgical management
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Illness Script PATHOPHYSIOLOGY ... Males=Females SIGNS ... DIAGNOSTICS: Clinical ... , neoplastic) TREATMENT ... #pulmonary